Your browser is no longer supported. Please, upgrade your browser.
NEW! Auto Refresh is now available in Screener. Let us know what you think. ×
NVO Novo Nordisk A/S daily Stock Chart
Novo Nordisk A/S
Index- P/E29.80 EPS (ttm)1.82 Insider Own- Shs Outstand2.08B Perf Week-0.26%
Market Cap112.68B Forward P/E23.89 EPS next Y2.27 Insider Trans- Shs Float1.42B Perf Month-3.21%
Income4.73B PEG1.99 EPS next Q0.50 Inst Own10.20% Short Float0.34% Perf Quarter-3.42%
Sales14.79B P/S7.62 EPS this Y7.40% Inst Trans-1.02% Short Ratio3.10 Perf Half Y-3.97%
Book/sh2.42 P/B22.41 EPS next Y13.50% ROA41.30% Target Price71.10 Perf Year23.33%
Cash/sh1.21 P/C44.65 EPS next 5Y15.00% ROE85.70% 52W Range41.08 - 60.34 Perf YTD30.18%
Dividend0.73 P/FCF43.99 EPS past 5Y23.20% ROI65.50% 52W High-10.11% Beta0.87
Dividend %1.35% Quick Ratio1.00 Sales past 5Y11.70% Gross Margin85.00% 52W Low32.05% ATR1.06
Employees40261 Current Ratio1.30 Sales Q/Q20.40% Oper. Margin46.30% RSI (14)50.99 Volatility1.34% 1.42%
OptionableYes Debt/Eq0.01 EPS Q/Q30.60% Profit Margin32.30% Rel Volume0.38 Prev Close53.95
ShortableYes LT Debt/Eq0.00 EarningsOct 29 BMO Payout39.40% Avg Volume1.56M Price54.24
Recom1.00 SMA200.28% SMA50-0.71% SMA200-0.46% Volume592,830 Change0.54%
Aug-28-15Initiated Leerink Partners Mkt Perform $56
Jun-09-15Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-15-15Initiated Societe Generale Sell
May-28-13Upgrade Deutsche Bank Sell → Hold
Mar-31-10Initiated Deutsche Bank Hold
Mar-30-10Downgrade Mehta Partners Outperform → Market Perform
Feb-24-10Upgrade Jefferies & Co Hold → Buy
Jan-15-10Downgrade Jefferies & Co Buy → Hold
Sep-11-09Initiated Jefferies & Co Buy
Aug-07-09Downgrade UBS Buy → Neutral
Aug-07-09Downgrade JP Morgan Overweight → Neutral
May-12-09Initiated Piper Jaffray Buy
Apr-24-09Upgrade Citigroup Hold → Buy
Mar-26-09Upgrade UBS Neutral → Buy
Jan-14-09Downgrade Citigroup Hold → Sell
Oct-06-08Upgrade Deutsche Securities Hold → Buy
Aug-29-08Downgrade Bernstein Mkt Perform → Underperform
Aug-21-08Initiated UBS Neutral
Jun-09-08Upgrade HSBC Securities Underweight → Neutral
Feb-26-08Downgrade Bear Stearns Outperform → Peer Perform
Nov-25-15 01:10PM  Novartis Gets EU Approval for Cardiovascular Drug Entresto
09:30AM  The Zacks Analyst Blog Highlights: Amphastar Pharmaceuticals, Mylan, Pernix Therapeutics Holdings, Eli Lilly and Novo Nordisk
Nov-24-15 04:32PM  Do Hedge Funds Love Comcast Corporation (CMCSK)? at Insider Monkey
12:09PM  Forget Allergan & Pfizer, Buy These Drug Stocks Instead
08:55AM  Back To The Future The Bull Rumbles Forward at Forbes
Nov-20-15 02:10PM  Like Ranges? These Are Stocks to Consider at Investopedia
12:50PM  Valeant to Up Incentives to Retain Key Employees Amid Turmoil
Nov-18-15 04:13PM  Novartis Announces Positive Results on Ultibro Breezhaler
09:10AM  Jefferies Reveals Top 5 Pharma Stock Picks for Growth and Dividends at 24/7 Wall St.
Nov-17-15 05:36PM  Mallinckrodt Gets FDA Nod for Inomax DS Plus MRI Device
04:50PM  Analysis of International Mutual Funds: Investor Takeaways
Nov-16-15 05:05PM  Roche's Lung Cancer Diagnostic Test Approved in the U.S.
Nov-15-15 11:15AM  Novo Nordisk shrugs off diabetes drugs gloom at Financial Times
Nov-14-15 01:19PM  Multi-Billion-Dollar Fund Renaissance Technologies Entered Q4 With These Top Picks at Insider Monkey
03:01AM  Very Little To Celebrate On World Diabetes Day at Forbes
Nov-11-15 01:11PM  Arrowstreet Capital Goes Heavily Bullish & Bets Big on These Stocks in Q4 at Insider Monkey
11:40AM  Danish Krone Fell and Inflation Was below the Forecasts
Nov-09-15 11:40AM  Novo Nordisk A/S Earnings Q3, 2015
Nov-08-15 03:45PM  Novo Nordisk diabetes drug fails to help heart failure -study
Nov-03-15 01:00PM  Billionaire Ken Fishers Top Healthcare Stock Picks at Insider Monkey
Nov-02-15 05:40PM  Novo Nordisk A/S Earnings: Benefiting From a Stronger Dollar at Motley Fool
Nov-01-15 09:41AM  These Drugs Could Deliver $5 Billion (or More) in Annual Sales at Motley Fool
Oct-30-15 11:17AM  Novo Nordisk (NVO) Beats on Q3 Earnings, Maintains View
Oct-29-15 12:40PM  Sanofi, Novo Nordisk Slide On Diabetes Headwinds at Investor's Business Daily -6.70%
09:04AM  [$$] Novo Nordisk Profit Jumps 29% but Earnings Growth Likely to Slow at The Wall Street Journal
08:29AM  Novo Nordisk Profit Beat Estimates
02:41AM  Novo Nordisk Profit Beats Estimates as Insulin Sales Climbed at Bloomberg
Oct-28-15 03:37PM  The JPMorgan Intrepid European Fund Class A (VEUAX): Historical Overview
Oct-26-15 11:07AM  Pfizers 3Q15 Earnings: Products Expected to Offset Growth
09:07AM  Pfizers 3Q15 Earnings: Expected Growth Contributors
Oct-22-15 04:30PM  Novo Nordisk Expands License Agreement with Emisphere
Oct-21-15 12:16PM  Abbott (ABT) Posts Higher-Than-Expected Q3 Earnings
Oct-16-15 02:16PM  New Deal Between Emisphere Technologies Inc. (EMIS) and Novo Nordisk A/S (ADR) (NVO) at Insider Monkey
Oct-15-15 04:40PM  Pfizer's Oral Formulation of Xeljanz Gets CRL from the FDA
08:21AM  Emisphere Signs License Agreement With Novo Nordisk to Develop Oral Formulations of Four Molecules Targeting Metabolic Indications and Amends GLP-1 Agreement GlobeNewswire
Oct-14-15 03:55PM  Abbott Labs Releases Data on Dissolving Heart Stent Absorb
Oct-13-15 07:00PM  Cramer: Why now is NOT the time to buy
04:35PM  How RTP factors in the Harvard Business Review's list of top CEOs at
Oct-12-15 05:02PM  Warren Buffett Not Top 100 CEO; Ex VW CEO Is No. 20 at Investor's Business Daily
Oct-08-15 10:32AM  Not Even Jim Simons Mathematical Models Could Pick Winning Stocks In Q3 at Insider Monkey
Oct-01-15 05:46PM  Celsion Begins Patient Enrollment in Ovarian Cancer Study
10:00AM  Xybion announces that Novo Nordisk selects Pristima to manage pharmacology research studies across all research sites PR Newswire
Sep-30-15 05:38PM  Why Novo Nordisk Is All in on New Diabetes Drug at TheStreet
05:35PM  Roche Presents Positive Data on Respiratory Drug Esbriet
03:49PM  Novo Nordisk Betting on New Long-Lasting Diabetes Drug to Dominate at TheStreet
Sep-28-15 04:30PM  Novo Nordisk's Tresiba & Ryzodeg Gain Entry into the U.S.
11:58AM  This is What Hedge Funds Have to Say about Two Healthcare Stocks on the Move at Insider Monkey
08:50AM  Is Novo Nordisk (NVO) Stock a Solid Choice Right Now?
04:22AM  Novo shares jump ahead of its largest ever drug launch Reuters
Sep-25-15 06:17PM  FDA approves 2 diabetes drugs from Novo Nordisk
05:03PM  FDA Clears Novo Nordisk Diabetes Drug at The Wall Street Journal
03:45PM  FDA approves Novo Nordisk's long-awaited diabetes drug Reuters
09:34AM  5 Toxic Stocks to Sell Now at TheStreet
Sep-23-15 03:06PM  How Pricing Affected Sanofis Diabetes Franchise in 2Q15
Sep-22-15 03:01PM  Enactment Of Clinton Prescription Drug Plan Will Result In R&D Job Losses at Forbes
09:11AM  Novo Nordisk to build ?70m plant in Iran at Financial Times
04:39AM  Novo Nordisk to build manufacturing plant in Iran AFP
Sep-21-15 12:07PM  European stocks rebound from worst drop in 2 weeks at MarketWatch
Sep-17-15 06:02PM  Novo Nordisk's Victoza Fares Better than Sanofi's Lyxumia
Sep-16-15 08:47AM  Novo to Probe One of Its Diabetes Drugs for Fatty Liver Disease at Bloomberg
12:00AM  Banking on Diabetes Epidemic, This Drugmaker Sits Out M&A Craze at Bloomberg
Sep-15-15 09:44AM  Analysts bet Novo's insulin drug will get U.S. green light Reuters
Sep-14-15 12:50PM  Jim Simons and Ken Fisher Decrease Exposure on Novo Nordisk A/S Gurufocus
Sep-09-15 07:29AM  Novo Nordisk (NVO) Sees Hammer Chart Pattern: Time to Buy?
Sep-08-15 06:23PM  Can Top Drugmaker Keep Boosting Sales, Stock Price? at Investor's Business Daily
Sep-03-15 04:40PM  Bristol-Myers' (BMY) Opdivo Gets Priority Review, Shares Up
06:15AM  Research and Markets: China Insulin Detemir (Novo Nordisk) Market Report 2010-2019 Business Wire
Sep-02-15 04:30PM  Bristol-Myers/AbbVie Cancer Drug Gets Priority Review
Aug-31-15 08:47AM  Is Novo Nordisk (NVO) an Incredible Growth Stock? 3 Reasons Why It Will Be Tough to Beat
Aug-28-15 10:25AM  Now the work starts for Novo Nordisk in Clayton at
09:50AM  Research and Markets: China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk Business Wire
06:29AM  Coverage initiated on Novo Nordisk A/S by Leerink Partners
Aug-27-15 03:30PM  Novo Nordisk to Start PIONEER Program on Semaglutide
07:17AM  Effective obesity management: It's more than reducing numbers on the scale PR Newswire
07:17AM  Effective obesity management: It's more than reducing numbers on the scale CNW Group
Aug-26-15 02:13PM  Novo Nordisk adding diabetes drug output in NC, Denmark
01:50PM  Nearly 700 N.C. jobs announced as part of $1.2B Novo Nordisk expansion at
09:38AM  Emisphere Highlights Eligen Licensee Novo Nordisk's Entry Into Phase 3a Development of Oral Semaglutide, a Once Daily Oral GLP-1 GlobeNewswire
Aug-24-15 01:40PM  Novo Nordisk A/S Q2 Earnings Analysis: By the Numbers, 2015
Aug-14-15 03:21PM  Jim Simons Betting On Microsoft, Colgate-Palmolive, Novo Nordisk & Alaska Air
09:43AM  Novo May Benefit From Possible Shire-Baxalta Disruption at Bloomberg
04:58AM  Biggest Insulin Maker May Build Next Diabetes Drug Plant in U.S. at Bloomberg
Aug-11-15 04:13AM  Moody's: Accelerated growth expected for EMEA Pharmaceuticals in 2016 at Moody's
Aug-07-15 06:23PM  Novo Nordisk's Net Income Up Y/Y, 2015 Outlook Maintained - Analyst Blog
Aug-06-15 08:16AM  We want to be seen as Chinese: Novo Nordisk at CNBC
07:42AM  China gets tougher for Western drugmakers
07:06AM  Novo Nordisk points to tough China market at Financial Times
07:06AM  Novo Nordisk points to tough China market
05:45AM  Research and Markets: Investigation Report on China's Liraglutide Market, 2011-2019 Featuring Novo Nordisk Business Wire
Aug-05-15 09:12AM  4 Pharmaceutical Stocks to Buy in Wake of Shire-Baxalta Bid at TheStreet
Jul-30-15 06:23PM  Six International Leaders Preparing To Report Results at Investor's Business Daily
Jul-24-15 11:12AM  AbbVie: Beware the Biosimilars? at
10:14AM  Appointment Notice - Novo Nordisk Canada Inc. PR Newswire
10:14AM  Appointment Notice - Novo Nordisk Canada Inc. CNW Group
Jul-16-15 12:18PM  Novo Nordisk says Flexpro PenMate gets FDA approval Reuters
Jul-15-15 09:48AM  Greece Is On The Verge Of A Health Catastrophe at Forbes
Jul-13-15 01:50PM  Novo Nordisk Up on Positive Results from Diabetes Study - Analyst Blog
Jul-10-15 12:59PM  Novo Nordisk's new GLP-1 diabetes drug hits goal in trial +5.31%
Jul-07-15 03:50PM  Versartis (VSAR) Up on Partial Hold Lift on Lead Candidate - Analyst Blog
01:04PM  Is This Novo Nordisk's Next Blockbuster Drug? at Motley Fool
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia care, growth hormone therapy, and hormone replacement therapy. The company markets and distributes its products through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S has a collaboration agreement with the Langer Laboratory for the development of next-generation drug delivery devices. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.